Cáncer Renal segunda línea - page 16

Plimack E et al. KCS 2016
CheckMate 025:
Survival benefit with Nivolumab
1...,6,7,8,9,10,11,12,13,14,15 17,18,19,20,21,22,23,24,25,26,...35
Powered by FlippingBook